Kraig Biocraft Laboratories Begins Operations in New Laboratory Print E-mail
By GLOBE NEWSWIRE   
Thursday, 14 December 2017 00:05

ANN ARBOR, Mich., Dec. 14, 2017 (GLOBE NEWSWIRE)

ANN ARBOR, Mich., Dec. 14, 2017 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (“Company”), the leading developer of spider silk based fibers, today announced that the Company has completed the build out of new laboratory space in its new research and production center.  The Company expects to begin the testing of existing spider silk formulations and the construction of new formulations before Christmas under its ongoing contract with the US Army to develop and deliver high performance spider silk polymers for protective applications. 

In just over two weeks the Company has staffed and equipped a fully functional laboratory and is now in the process of developing the next generation of spider silk products.  Consistent with the Company’s Ethos of efficiency and

frugality, the lab was finished ahead of schedule, and under budget. 

“The opening of this new Lab is a watershed moment for the Company,” said Jon Rice, COO.  “Our new facility gives us the capacity to design, develop, and test new Spider Silk formulations, which give us the ability to rapidly develop new products going into 2018. We have brought on additional staff over the last 60 days, to take our ground breaking Spider Silk technology to the next level. Recent developments have reinvigorated our team, making us as excited today, as we were when we began our journey.”

About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and

Error. Page cannot be displayed. Please contact your service provider for more details. (19)

expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and
assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.


Ben Hansel, Hansel Capital, LLC
(720) 288-8495
ir@KraigLabs.com

Primary Logo




BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!
 

Newsletter

BMR:1